📣 We’re providing up to $4.6M to advance DegradaBALL®, an mRNA drug delivery technology developed by Lemonex in Korea, which has the potential to both minimise post-mRNA vaccination side effects and improve access to future mRNA vaccines.
https://t.co/wYOAsqVAqU
LEM-mR203 is a safer and more efficient mRNA vaccine candidate by applying DegradaBALL® technology that can complement the limitations of LNP. https://t.co/KD1S13H7sd
Lemonex has developed an innovative DDS nanoparticle, DegradaBALL, which enables safer and more effective gene therapy. Currently, mRNA-DegradaBALL system enhaned thermo-stability of mRNA vaccine for three months over in low temperature.
#Lemonex#DegradaBALL#mRNA